PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.\', \'Department of Pharmacy Services, Mayo Clinic, Rochester, Minnesota 55905, United States.\', \'Division of Biostatistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, United States.\', \'College of Letters and Science, University of California, Berkeley, Berkeley, California 55906, United States.\', \'Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.molpharmaceut.0c00608
?:hasPublicationType
?:journal
  • Molecular pharmaceutics
is ?:pmid of
?:pmid
?:pmid
  • 33464914
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.572
?:rankingScore_hIndex
  • 102
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33464914>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33464914>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all